Drug giants GlaxoSmithKline and Novartis are being taken to court by Australia's consumer watchdog over "false or misleading" claims in the marketing of pain relief products, it was announced Wednesday.
The case by the Australian Competition and Consumer Commission centres around their Voltaren Osteo Gel and Voltaren Emulgel lines.
It claims they represented Osteo Gel on its packaging and online as specifically formulated for treating osteoarthritis and was more effective than Emulgel, when they had identical formulas.
Both products contain the same active ingredient, diclofenac diethylammonium gel 11.6mg/g, which acts in a non-specific manner to reduce local pain and inflammation wherever it is applied.
GMT 08:29 2017 Thursday ,07 December
Australia parliament passes same-sex marriage billGMT 06:42 2017 Wednesday ,29 November
Australian Senate passes gay marriage bill in key stepGMT 15:03 2017 Tuesday ,21 November
BHP, Vale get more time to settle Samarco mine disaster claimGMT 10:45 2017 Tuesday ,07 November
Sydney car hits classroom killing two boysGMT 07:03 2017 Thursday ,07 September
Dismisses challenge to gay marriage postal voteMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor